Monogenic non-syndromic obesity
Monogenic non-syndromic obesity
Also known as:Monogenic obesity; non-syndromic genetic obesity; China Second Rare Disease Catalog item 50
Monogenic non-syndromic obesity is early-onset severe obesity caused by a single-gene change that often affects hunger, fullness, and energy regulation rather than willpower.
Start Here
A quick guide to the next step: which department to start with, what to prepare, and what to ask.
Start with pediatric endocrinology or endocrinology and metabolism, with nutrition, psychology, and medical genetics support. The goal is to identify biology and reduce blame.
Many forms affect the leptin-melanocortin pathway. A child may be normal weight at birth but develop rapid early weight gain, poor satiety, and repeated food-seeking.
Care includes non-stigmatizing lifestyle support, complication screening, and psychological and family support. Some people with POMC, PCSK1, or LEPR deficiency may be eligible for setmelanotide where available.
Genes can include LEP, LEPR, POMC, PCSK1, MC4R, SIM1, and others. Inheritance depends on the gene, and results may affect family testing and treatment options.
Families may be told the problem is simply overeating or poor self-control, while intense hunger, early onset, family history, and endocrine clues are missed.
This page helps patients and families organize care leads. It does not replace a clinician’s diagnosis or treatment plan. For testing, medication, referrals, emergency care, and support applications, follow qualified clinicians, medical institutions, support organizations, and official sources.
Diagnosis Path
Organized around the practical patient journey: identify clues, avoid common delays, then prepare for care.
When to Suspect It
- Rapid, severe weight gain before age 5 with intense persistent hunger, poor satiety, or repeated food-seeking.
- The family has made sustained diet and activity changes, but weight gain and hunger remain unusually strong.
- Endocrine clues such as red hair and adrenal issues for POMC, hypoglycemia or chronic diarrhea for PCSK1, or puberty or immune issues for LEPR.
- Family history of early severe obesity, consanguinity, or similarly affected siblings.
Common Wrong Turns
- Focusing on willpower or blaming the family instead of evaluating biology behind early severe obesity and hyperphagia.
- Giving general weight advice without screening for sleep apnea, fatty liver, glucose metabolism, blood pressure, and mental health.
- Assuming all genetic obesity is syndromic and overlooking single-gene non-syndromic forms without obvious malformations or intellectual disability.
Departments to Start With
- Pediatric endocrinology
- Endocrinology and metabolism
- Medical genetics
- Nutrition and psychology support clinic
Before the Visit
- Bring height, weight, and BMI curves from birth onward and note the age when rapid gain began.
- Record hunger, food-seeking, night eating, satiety, family interventions tried, and barriers to activity.
- Bring glucose, insulin, lipid, liver, thyroid, cortisol, sleep breathing, and liver imaging results.
- Prepare family weight history, consanguinity, puberty, immune, diarrhea, hypoglycemia, and adrenal history.
Tests to Ask About
- Growth chart review and endocrine evaluation to exclude hypothyroidism, Cushing syndrome, hypothalamic injury, and medication-related weight gain.
- Genetic testing for monogenic obesity genes such as LEP, LEPR, POMC, PCSK1, MC4R, and SIM1.
- Complication screening: glucose tolerance or HbA1c, lipids, liver tests and fatty liver, blood pressure, sleep apnea, joints, and mental health.
- If a treatable pathway is found, whether setmelanotide or a clinical study is available and appropriate.
Questions for the Doctor
- Do these signs suggest monogenic obesity rather than common polygenic or syndromic obesity?
- How would genetic results change treatment, family testing, and reproductive counseling?
- How can we manage intense hunger while protecting the child from shame and anxiety?
- Which complications should be screened for, and are targeted medicines or studies available?
Basic Information
Medical Notes
More complete medical explanations are kept here for discussion with clinicians.
Symptoms
Monogenic non-syndromic obesity usually causes rapid severe weight gain beginning in infancy or early childhood, often with marked hyperphagia, poor satiety, repeated food-seeking, and hunger soon after eating. There may be no obvious syndromic facial features or multiple malformations, which can lead to misunderstanding.
Different genes can bring different clues. POMC deficiency may involve red hair, pale skin, and adrenal insufficiency; PCSK1 deficiency can include hypoglycemia, diarrhea, or endocrine problems; LEPR deficiency may involve puberty or immune issues. MC4R-related obesity is relatively more common and can feature early severe obesity and accelerated linear growth.
Diagnosis
Diagnosis starts with the growth curve: age at onset, BMI trajectory, hunger pattern, and family history are central. Clinicians also exclude hypothyroidism, Cushing syndrome, hypothalamic disease, medication-related weight gain, syndromic obesity, and common polygenic obesity.
Genetic testing is worth discussing when severe obesity starts before age 5, hyperphagia is prominent, family clustering is present, or endocrine clues exist. Results should be interpreted by genetics or endocrinology teams because gene, variant classification, and inheritance pattern affect diagnostic certainty, relative testing, and treatment choices.
Treatment
Care should not start with blame. Core management includes structured nutrition, supportive home environments, activity matched to ability, sleep support, psychological care, and school coordination, while screening for glucose abnormalities, fatty liver, high blood pressure, dyslipidemia, sleep apnea, joint pain, and emotional distress.
Targeted treatment is changing care for some gene-defined forms. Setmelanotide has been approved in some countries for genetically confirmed obesity due to POMC, PCSK1, or LEPR deficiency; eligibility depends on the genetic result, age, local approval, and access. Severe cases may also need individualized discussion of medicines, metabolic surgery, or research options.
Long-term Care
Long-term care should aim to reduce complications and improve quality of life, not focus only on the number on the scale. Follow-up can track height, weight, waist, blood pressure, sleep, liver and metabolic markers, bullying, eating distress, anxiety, depression, and family stress.
Families can work with clinicians on realistic environmental strategies such as regular meals, reducing high-trigger food exposure, protecting sleep, and choosing activity the child can sustain, while avoiding shame, punishment, or extreme dieting.
Fertility and Family
Genetic risk depends on the specific gene and inheritance pattern. In autosomal recessive forms, parents may both be carriers; in autosomal dominant forms, relatives may have variable expression. After diagnosis, family testing, carrier counseling, and reproductive options should be discussed.
When to Seek Urgent Care
Urgent care is needed for severe hypoglycemia, altered consciousness, dehydration, persistent vomiting or diarrhea, suspected adrenal crisis, markedly worsening sleep-related breathing, chest pain, or mental health crisis. People using targeted or other weight-management medicines should contact the care team promptly for severe allergy, major mood change, or other serious side effects flagged by their clinician.
Prognosis
Long-term outcome depends on the gene, complication control, family and psychological support, and access to targeted therapy. Early diagnosis can reduce blame and avoidable delay.